Protein & Biomolecular Sequence Modeling
Quantifying and Mitigating Surrogate Oracle Exploitation in Biomolecular Sequence Optimization
Generated automatically from the limitations stated in 4 papers (ICML, ICLR), listed under Evidence. It is not a paper, and it does not come from papers submitted to CSPaper.
The problem
Generative and reinforcement learning methods for protein design optimize against learned fitness predictors or computational proxies (such as ESMFold or AutoDock Vina) rather than ground-truth biophysical assays. As optimization progresses, generated sequences exploit the blind spots and low-label estimation errors of these surrogates, producing candidates with inflated reward scores that fail in true physical or experimental evaluations. Because contemporary literature routinely evaluates generated designs using the same surrogates that guided optimization, reported performance gains frequently reflect proxy over-optimization rather than genuine biophysical efficacy.
Why it matters
Enables trustworthy offline protein design pipelines where in silico reward gains translate to valid biophysical candidates. Establishes standard evaluation protocols that distinguish true generative capability from surrogate hacking.
Ways to approach it
Prior-work checks are free with an account. Results someone already ran are shown to everyone.
- 1
Systematic over-optimization audit: Implement standard sequence optimizers (e.g., GFlowNets, RL, evolutionary search) against proxy fitness predictors across established benchmarks (e.g., ProteinGym), tracking proxy reward versus ground-truth/high-fidelity validation oracles over optimization trajectories. Measure the divergence point where proxy scores decouple from true fitness across varied training label budgets.
- 2
Pessimistic and uncertainty-guided surrogate objectives: Incorporate ensemble-based epistemic uncertainty penalties (e.g., lower confidence bounds) or protein language model representation density penalties into the reward objective. Measure the retention of true oracle fitness compared to unpenalized surrogate optimization.
- 3
Multi-surrogate consensus Pareto optimization: Evaluate multi-objective sequence generation across orthogonal oracle modalities (sequence-likelihood, structural prediction, and physical docking) to measure whether cross-modal consensus prevents single-predictor exploitation.
Have a different approach?
Describe how you would tackle this problem and we'll look for papers that already do it. Free; your text stays private.
Why it might fail
High-fidelity validation oracles (such as extensive MD simulations or costly multiplexed wet-lab assays) may be too noisy or computationally prohibitive to establish a definitive ground-truth benchmark. Alternatively, the issue may be partially dissolved if trivial ensembling of existing foundation model embeddings already eliminates proxy exploitation across standard test sets.
Evidence
Each paper's own statement of the limitation, verbatim.
- Iterative Distillation for Reward-Guided Fine-Tuning of Diffusion Models in Biomolecular DesignICLR 2026
Relies on surrogate oracle models for biological rewards which can still be susceptible to over-optimization if surrogate models have blind spots.
- FIDIA: Function-Informed Sequence Design via Inference-Aligned Policy OptimizationICML 2026
Susceptible to inaccuracies and biases inherent in surrogate reward oracles (e.g., ESMFold, AutoDock Vina).
- Robust Optimization in Protein Fitness Landscapes Using Reinforcement Learning in Latent SpaceICML 2024
Performance depends on oracle quality: using a fitness predictor as surrogate reward yields lower fitness than direct oracle feedback in all tasks, and results rely on checkpoints from Kirjner et al. (2023)
- Knowledge-aware Reinforced Language Models for Protein Directed EvolutionICML 2024
Reward comes from a learned fitness predictor (pseudo reward), so performance depends on predictor quality under low-label regimes; oracle annotation cost and predictor error accumulation are not analyzed
Nearest existing work
- ProSpero: Active Learning for Robust Protein Design Beyond Wild-Type NeighborhoodsNeurIPS 2025
- A Variational Perspective on Generative Protein Fitness OptimizationICML 2025
- Proximal Exploration for Model-guided Protein Sequence DesignICML 2022
- Robust Optimization in Protein Fitness Landscapes Using Reinforcement Learning in Latent SpaceICML 2024
- Interpretability Driven Evolutionary Approach for the Design of Biological SequencesICML 2026
- Improved Off-policy Reinforcement Learning in Biological Sequence DesignICML 2025
- Data Distillation for extrapolative protein design through exact preference optimizationICLR 2025
- Unifying Likelihood-free Inference with Black-box Optimization and BeyondICLR 2022
- Importance Weighted Expectation-Maximization for Protein Sequence DesignICML 2023
- Conditioning by adaptive sampling for robust designICML 2019
- Model-based reinforcement learning for biological sequence designICLR 2020
- Steering Generative Models with Experimental Data for Protein Fitness OptimizationNeurIPS 2025
- Multi-Objective Protein Design via Memory-Aware Test-Time Scaling in Diffusion ModelsICML 2026
- ProteinNPT: Improving Protein Property Prediction and Design with Non-Parametric TransformersNeurIPS 2023
- ProtInvTree: Deliberate Protein Inverse Folding with Reward-guided Tree SearchNeurIPS 2025
Related open problems
Protein & Biomolecular Sequence Modeling
Benchmarking the Fidelity of In Silico Protein Design Proxies Against Experimental Biophysical Assays
Generative biomolecular modeling currently assesses sequence designs almost entirely through computational surrogates—such as AlphaFold confidence (pLDDT/pTM), ESMFold self-consistency, and Rosetta energy terms—rather than physical assay measurements. Because these proxies serve as both optimization objectives and evaluation metrics, models risk overfitting to artifacts of structure-prediction heuristics rather than true biophysical viability. Without systematic evaluation against physical assays across sequence design methods, it remains unknown whether improvements on in silico leaderboards translate to viable expression, foldability, or binding in physical systems.
Protein & Biomolecular Sequence Modeling
A Systematic Robustness Study of Genomic Foundation Models Beyond the Human Reference Genome
Current genomic sequence models are predominantly pretrained and evaluated strictly on the single human reference genome (GRCh38/hg38). Consequently, it remains unknown whether representations trained on a single reference sequence maintain their predictive capabilities across distinct chromosomes, across individual genetic variation in population-scale cohorts, or across non-human species genomes. Without cross-setting robustness benchmarks, practitioners cannot determine whether model performance transfers to non-reference genomic contexts or degrades under distribution shifts.
Protein & Biomolecular Sequence Modeling
Benchmarking Surrogate-Trained Sequence Optimization Against Empirical Fitness Landscapes
Current machine learning models for protein and biomolecular sequence design are evaluated almost exclusively against learned surrogate oracles (such as CNN fitness predictors) rather than verified experimental outcomes. Because black-box optimizers can easily exploit surrogate artifacts and out-of-distribution prediction errors, reported in-silico fitness gains often fail to reflect actual biological activity. Without systematic evaluation across empirically ground-truthed landscapes, it is unknown which sequence design methods reliably find functional sequences versus which merely overfit to computational evaluator flaws.
Protein & Biomolecular Sequence Modeling
Benchmarking and Mitigating Model Sensitivity to Predicted Structure Quality in Protein Sequence Modeling
Current structure-conditioned protein sequence and representation models routinely filter out test proteins with predicted confidence scores below pLDDT 70 or assume near-experimental coordinate fidelity. Consequently, these models cannot reliably be applied to disordered proteins, orphan sequences, or hard-to-predict folds where high-confidence static predictions do not exist. Downstream pipelines experience unquantified error propagation when forced to consume predicted structures from AlphaFold2 or ESMFold, yet no systematic evaluation exists mapping how performance degrades across the full spectrum of structural prediction quality.